Priority review vouchers: an inefficient and dangerous way to promote neglected-disease drug development.
作者信息
Kesselheim A S
机构信息
Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
出版信息
Clin Pharmacol Ther. 2009 Jun;85(6):573-5. doi: 10.1038/clpt.2009.50.
PMID:19451908
Abstract
摘要
Zotero 插件